Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

British Journal of Cancer

Volumn 85, Issue 11, 2001, Pages 1706-1712

  Shou, Y ^a,b   Hirano, T ^a   Gong, Y ^a   Kato, Y ^a   Yoshida, K ^a   Ohira, T ^a   Ikeda, N ^a   Konaka, C ^a   Ebihara, Y ^a   Zhao, F ^b   Kato, H ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Basic fibroblast growth factor; Matrix metalloproteinase 9; Matrix metatloproteinase 2; Non small cell lung carcinoma; Platelet derived growth factor; Vascular endothelial growth

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035977176     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2137     Document Type: Article

References (56)

1. Molecular aspects of tumor cell invasion and metastasis
2. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma
3. MMP inhibitors: Experimental and clinical studies
4. Matrix metalloproteinase- 9 triggers the angiogenic switch during carcinogenesis
5. Matrix metalloproteinase-9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer
6. Matrix metalloproteinases in tumour invasion and metastasis
7. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients
8. Significant changes in the distribution of histologic types of lung cancer. A review of 4928 cases
9. Tumor angiogenesis
10. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma
11. Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study
12. Expression of vascular endothelial growth factor related in 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors
13. Angiogenesis research up to 1996. A commentary on the state of art and suggestions for further studies
14. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation
15. C-erbB-2 oncoprotein expression in operable non-small cell lung cancer
16. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer
17. Randomized trial of lobectomy versus limited resection for T1 No non-small cell lung cancer
18. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells
19. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression
20. Three-dimensional type-I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
21. Contribution of c-erbB-2 and topoisomerase 11alpha to chemoresistance in ovarian cancer
22. Matrix metalloproteinase regulate neovascularization by acting as pericellular fibrinolysins
23. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
24. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
25. Matrix metalloproteinases
26. p185neu expression in human lung adenocarcinomas predicts shortened survival
27. Matrix metalloproteinases and metastasis
28. Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung
29. Development and characterization of IC6-203, a new monoclonal antibody specific to human thymidine phosphorylase
30. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer
31. Malignancy of gastric cancer analyzed by the expression of thymidine phosphorylase
32. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity
33. Revisions in the international system for staging lung cancer
34. Matrix metalloproteinses: Biological activity and clinical implications
35. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
36. Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and Mitomycin C on the growth and liver metastasis of human colon cancer
37. Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas
38. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer
39. Tumour angiogenesis and recurrence in stage I non-small cell lung cancer
40. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer
41. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
42. Lack of pregnostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: An immunohistochemical study on cryosections
43. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining
44. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
45. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic
46. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small cell lung cancer
47. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers
48. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma
49. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
50. Correlation between longterm survival in breast cancer patients and amplification of two putative oncogene- coamplification units: hst-1/int-2 and c-erbB-2/ear-1
51. Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma
52. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro
53. PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis
54. Matrilysin: An epithelial matrix metalloproteinase with potentially novel functions
55. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
56. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment